Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

CHOP Chemotherapy for Aggressive Non-Hodgkin Lymphoma with and without HIV in the Antiretroviral Therapy Era in Malawi

UNC Libraries(2020)10.17615/ds12-1b06Source: DataRank Database

CHOP Chemotherapy for Aggressive Non-Hodgkin Lymphoma with and without HIV in the Antiretroviral Therapy Era in Malawi is a research paper published in UNC Libraries (2020). On theSindex it has a DataRank of 0.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access0 citations

Free full text

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (8 grants)Impact (FWCI 0.00)OA: greenTopics (49)IDs (PubMed, OpenAlex)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (21)

Edwards Kasonkanji ORCID,Thomas C. Shea,Victor Makwakwa,Bongani Kaimila ORCID,Richard Nyasosela

Live enrichment

PubMed:23304386 OpenAlex:https://openalex.org/W4298380644

National Institutes of Health

Grant: 3U01CA121947-05S1

UCSF Core Site

National Institutes of Health

Grant: 3U54CA190152-05S1

Addressing Herpesvirus-associated Cancers through the UNC-Malawi Cancer Consortiu

National Institutes of Health

Grant: 5P30CA016086-33

CORE--PROTEOMICS

National Institutes of Health

Grant: 5U54CA190152-04

Addressing Herpesvirus-associated Cancers through the UNC-Malawi Cancer Consortiu

National Institutes of Health

Grant: 4K01TW009488-05

Developing a clinical cohort of histopathologically characterized lymphoma

National Institutes of Health

Grant: 1R21CA180815-01

Molecular profiling of HIV-associated lymphoma in the US and Malawi

National Institutes of Health

Grant: 3P30CA016086-42S2

Cancer Center Support Grant

National Institutes of Health

Grant: 3U2GPS001965-05S1

SUPPORTING THE SCALE-UP HIGH QUALITY HIV CARE AND TREATMENT PROGRAMS IN MALAWI

FWCI

0.00

Citation Percentile

0.3%

greenLicense: CC BY

repositoryhttps://doi.org/10.17615/ds12-1b06

https://doi.org/10.1371/journal.pone.0150445

https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0150445&type=printable

https://dx.doi.org/10.17615/ds12-1b06

https://dx.doi.org/10.60692/x9tpy-4rb14

Fields of Study

Viral-associated cancers and disordersChronic Lymphocytic Leukemia ResearchLymphoma Diagnosis and Treatment03 medical and health sciences0302 clinical medicine

Keywords

CHOPAntiretroviral therapyMedicineHuman immunodeficiency virus (HIV)LymphomaHodgkin lymphomaChemotherapyOncologyInternal medicineVirologyViral loadAdultMaleMalawiNeutropeniaScienceHIV InfectionsPathology and Forensic MedicineAntineoplastic Combined Chemotherapy ProtocolsHealth SciencesHumansPost-Transplant Lymphoproliferative DiseaseLymphoid NeoplasmsCyclophosphamideLymphoma, Non-HodgkinQRGastroenterologyNon-Hodgkin's lymphomaDiffuse large B-cell lymphomaMiddle AgedSurvival AnalysisInternational Prognostic IndexDiagnosis and Treatment of Primary Central Nervous System LymphomaNeurologyDoxorubicinVincristineAntirheumatic AgentsAggressive lymphomaPrednisoneFemaleViral-Related Cancers in Immunocompromised PatientsRituximabResearch Article

Sustainable Development Goals

SDG 3: 3. Good healthSDG 0: Good health and well-being